A

Agile Therapeutics Inc
F:0AL

Watchlist Manager
Agile Therapeutics Inc
F:0AL
Watchlist
Price: 1.11 EUR -1.77% Market Closed
Market Cap: 9.3m EUR

Operating Margin
Agile Therapeutics Inc

-74.2%
Current
-1 349%
Average
6%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-74.2%
=
Operating Profit
-15.9m
/
Revenue
21.5m

Operating Margin Across Competitors

No Stocks Found

Agile Therapeutics Inc
Glance View

Market Cap
9.3m EUR
Industry
Pharmaceuticals

Agile Therapeutics, Inc. is a healthcare company, which engages in the development and commercialization of transdermal patch. The company is headquartered in Princeton, New Jersey and currently employs 30 full-time employees. The company went IPO on 2014-05-22. The Company’s sole approved product, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive. Twirla is a method of contraception for use in women of reproductive potential for whom a combined hormonal contraceptive is appropriate. Twirla is a prescription combined hormonal contraceptive patch, which contains the active ingredients ethinyl estradiol (EE), which is a synthetic estrogen and levonorgestrel (LNG), which is a type of progestin. Twirla delivers 30 micrograms of EE per day, a dose of EE consistent with the dose delivered by many commonly prescribed oral contraceptives. The firm commercializes Twirla in the United States. Twirla leverages the Company’s transdermal patch technology called Skinfusion. Skinfusion is designed to allow drug delivery through the skin while optimizing patch adhesion and patient comfort and wearability.

0AL Intrinsic Value
Not Available
A
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-74.2%
=
Operating Profit
-15.9m
/
Revenue
21.5m
What is the Operating Margin of Agile Therapeutics Inc?

Based on Agile Therapeutics Inc's most recent financial statements, the company has Operating Margin of -74.2%.

Back to Top